Avail up to 50% Thanksgiving Discount on all our reports. Stay safe

Global Rare Disease Treatment Market Size, Status and Forecast 2018-2025

Date: Sep 20 2018
|
QYRESEARCH
|
Number of Pages: 108
|
Alternate Text Alternate Text Alternate Text Alternate Text
Category: Medical Care

This report focuses on the global Rare Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rare Disease Treatment development in United States, Europe and China.

A rare disease is any disease that affects a small percentage of the population.
Most rare diseases are genetic and thus are present throughout the person's entire life, even if symptoms do not immediately appear.
In 2017, the global Rare Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Novartis
Pfizer
F. Hoffmann-La Roche
Celgene
AbbVie
Johnson & Johnson
Shire
Alexion
Novo Nordisk
Sanofi
Bayer
Amgen
Allergan
Eisai
Bristol-Myers Squibb
Merck
Vertex Pharmaceuticals
Baxter
BioMarin
Teva Pharmaceutical Industries

Market segment by Type, the product can be split into
Originator Drugs
Generic Drugs

Market segment by Application, split into
Hospital Pharmacies
Specialty Pharmacies
Retail Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Rare Disease Treatment status, future forecast, growth opportunity, key market and key players.
To present the Rare Disease Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Rare Disease Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents
1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
           1.4.1 Global Rare Disease Treatment Market Size Growth Rate by Type (2013-2025)
           1.4.2 Originator Drugs
           1.4.3 Generic Drugs
    1.5 Market by Application
           1.5.1 Global Rare Disease Treatment Market Share by Application (2013-2025)
           1.5.2 Hospital Pharmacies
           1.5.3 Specialty Pharmacies
           1.5.4 Retail Pharmacies
    1.6 Study Objectives
    1.7 Years Considered
2 Global Growth Trends
    2.1 Rare Disease Treatment Market Size
    2.2 Rare Disease Treatment Growth Trends by Regions
           2.2.1 Rare Disease Treatment Market Size by Regions (2013-2025)
           2.2.2 Rare Disease Treatment Market Share by Regions (2013-2018)
    2.3 Industry Trends
           2.3.1 Market Top Trends
           2.3.2 Market Drivers
           2.3.3 Market Opportunities
3 Market Share by Key Players
    3.1 Rare Disease Treatment Market Size by Manufacturers
           3.1.1 Global Rare Disease Treatment Revenue by Manufacturers (2013-2018)
           3.1.2 Global Rare Disease Treatment Revenue Market Share by Manufacturers (2013-2018)
           3.1.3 Global Rare Disease Treatment Market Concentration Ratio (CR5 and HHI)
    3.2 Rare Disease Treatment Key Players Head office and Area Served
    3.3 Key Players Rare Disease Treatment Product/Solution/Service
    3.4 Date of Enter into Rare Disease Treatment Market
    3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
    4.1 Global Rare Disease Treatment Market Size by Type (2013-2018)
    4.2 Global Rare Disease Treatment Market Size by Application (2013-2018)
5 United States
    5.1 United States Rare Disease Treatment Market Size (2013-2018)
    5.2 Rare Disease Treatment Key Players in United States
    5.3 United States Rare Disease Treatment Market Size by Type
    5.4 United States Rare Disease Treatment Market Size by Application
6 Europe
    6.1 Europe Rare Disease Treatment Market Size (2013-2018)
    6.2 Rare Disease Treatment Key Players in Europe
    6.3 Europe Rare Disease Treatment Market Size by Type
    6.4 Europe Rare Disease Treatment Market Size by Application
7 China
    7.1 China Rare Disease Treatment Market Size (2013-2018)
    7.2 Rare Disease Treatment Key Players in China
    7.3 China Rare Disease Treatment Market Size by Type
    7.4 China Rare Disease Treatment Market Size by Application
8 Japan
    8.1 Japan Rare Disease Treatment Market Size (2013-2018)
    8.2 Rare Disease Treatment Key Players in Japan
    8.3 Japan Rare Disease Treatment Market Size by Type
    8.4 Japan Rare Disease Treatment Market Size by Application
9 Southeast Asia
    9.1 Southeast Asia Rare Disease Treatment Market Size (2013-2018)
    9.2 Rare Disease Treatment Key Players in Southeast Asia
    9.3 Southeast Asia Rare Disease Treatment Market Size by Type
    9.4 Southeast Asia Rare Disease Treatment Market Size by Application
10 India
    10.1 India Rare Disease Treatment Market Size (2013-2018)
    10.2 Rare Disease Treatment Key Players in India
    10.3 India Rare Disease Treatment Market Size by Type
    10.4 India Rare Disease Treatment Market Size by Application
11 Central & South America
    11.1 Central & South America Rare Disease Treatment Market Size (2013-2018)
    11.2 Rare Disease Treatment Key Players in Central & South America
    11.3 Central & South America Rare Disease Treatment Market Size by Type
    11.4 Central & South America Rare Disease Treatment Market Size by Application
12 International Players Profiles
    12.1 Novartis
           12.1.1 Novartis Company Details
           12.1.2 Company Description and Business Overview
           12.1.3 Rare Disease Treatment Introduction
           12.1.4 Novartis Revenue in Rare Disease Treatment Business (2013-2018)
           12.1.5 Novartis Recent Development
    12.2 Pfizer
           12.2.1 Pfizer Company Details
           12.2.2 Company Description and Business Overview
           12.2.3 Rare Disease Treatment Introduction
           12.2.4 Pfizer Revenue in Rare Disease Treatment Business (2013-2018)
           12.2.5 Pfizer Recent Development
    12.3 F. Hoffmann-La Roche
           12.3.1 F. Hoffmann-La Roche Company Details
           12.3.2 Company Description and Business Overview
           12.3.3 Rare Disease Treatment Introduction
           12.3.4 F. Hoffmann-La Roche Revenue in Rare Disease Treatment Business (2013-2018)
           12.3.5 F. Hoffmann-La Roche Recent Development
    12.4 Celgene
           12.4.1 Celgene Company Details
           12.4.2 Company Description and Business Overview
           12.4.3 Rare Disease Treatment Introduction
           12.4.4 Celgene Revenue in Rare Disease Treatment Business (2013-2018)
           12.4.5 Celgene Recent Development
    12.5 AbbVie
           12.5.1 AbbVie Company Details
           12.5.2 Company Description and Business Overview
           12.5.3 Rare Disease Treatment Introduction
           12.5.4 AbbVie Revenue in Rare Disease Treatment Business (2013-2018)
           12.5.5 AbbVie Recent Development
    12.6 Johnson & Johnson
           12.6.1 Johnson & Johnson Company Details
           12.6.2 Company Description and Business Overview
           12.6.3 Rare Disease Treatment Introduction
           12.6.4 Johnson & Johnson Revenue in Rare Disease Treatment Business (2013-2018)
           12.6.5 Johnson & Johnson Recent Development
    12.7 Shire
           12.7.1 Shire Company Details
           12.7.2 Company Description and Business Overview
           12.7.3 Rare Disease Treatment Introduction
           12.7.4 Shire Revenue in Rare Disease Treatment Business (2013-2018)
           12.7.5 Shire Recent Development
    12.8 Alexion
           12.8.1 Alexion Company Details
           12.8.2 Company Description and Business Overview
           12.8.3 Rare Disease Treatment Introduction
           12.8.4 Alexion Revenue in Rare Disease Treatment Business (2013-2018)
           12.8.5 Alexion Recent Development
    12.9 Novo Nordisk
           12.9.1 Novo Nordisk Company Details
           12.9.2 Company Description and Business Overview
           12.9.3 Rare Disease Treatment Introduction
           12.9.4 Novo Nordisk Revenue in Rare Disease Treatment Business (2013-2018)
           12.9.5 Novo Nordisk Recent Development
    12.10 Sanofi
           12.10.1 Sanofi Company Details
           12.10.2 Company Description and Business Overview
           12.10.3 Rare Disease Treatment Introduction
           12.10.4 Sanofi Revenue in Rare Disease Treatment Business (2013-2018)
           12.10.5 Sanofi Recent Development
    12.11 Bayer
    12.12 Amgen
    12.13 Allergan
    12.14 Eisai
    12.15 Bristol-Myers Squibb
    12.16 Merck
    12.17 Vertex Pharmaceuticals
    12.18 Baxter
    12.19 BioMarin
    12.20 Teva Pharmaceutical Industries
13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
    15.1 Research Methodology
           15.1.1 Methodology/Research Approach
                 15.1.1.1 Research Programs/Design
                 15.1.1.2 Market Size Estimation
                 12.1.1.3 Market Breakdown and Data Triangulation
           15.1.2 Data Source
                 15.1.2.1 Secondary Sources
                 15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details

List of Tables and Figures
Table Rare Disease Treatment Key Market Segments
Table Key Players Rare Disease Treatment Covered
Table Global Rare Disease Treatment Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Rare Disease Treatment Market Size Market Share by Type 2013-2025
Figure Originator Drugs Figures
Table Key Players of Originator Drugs
Figure Generic Drugs Figures
Table Key Players of Generic Drugs
Table Global Rare Disease Treatment Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Specialty Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Rare Disease Treatment Report Years Considered
Table Global Rare Disease Treatment Market Size 2013-2025 (Million US$)
Figure Global Rare Disease Treatment Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Rare Disease Treatment Market Size by Regions 2013-2025 (Million US$)
Table Global Rare Disease Treatment Market Size by Regions 2013-2018 (Million US$)
Table Global Rare Disease Treatment Market Share by Regions 2013-2018
Figure Global Rare Disease Treatment Market Share by Regions 2013-2018
Figure Global Rare Disease Treatment Market Share by Regions 2018
Table Market Top Trends
Table Global Rare Disease Treatment Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Rare Disease Treatment Market Share by Manufacturers (2013-2018)
Figure Global Rare Disease Treatment Market Share by Manufacturers in 2018
Table Global Rare Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Rare Disease Treatment Product/Solution/Service
Table Date of Enter into Rare Disease Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Rare Disease Treatment Market Size by Type (2013-2018) (Million US$)
Table Global Rare Disease Treatment Market Size Share by Type (2013-2018)
Figure Global Rare Disease Treatment Market Size Market Share by Type (2013-2018)
Table Global Rare Disease Treatment Market Size by Application (2013-2018) (Million US$)
Table Global Rare Disease Treatment Market Size Share by Application (2013-2018)
Figure Global Rare Disease Treatment Market Size Market Share by Application (2013-2018)
Figure Global Rare Disease Treatment Revenue Market Share by Application in 2017
Figure United States Rare Disease Treatment Market Size 2013-2018 (Million US$)
Table United States Key Players Rare Disease Treatment Revenue (2017-2018) (Million US$)
Table United States Key Players Rare Disease Treatment Market Share (2017-2018)
Table United States Rare Disease Treatment Market Size by Type (2013-2018) (Million US$)
Table United States Rare Disease Treatment Market Share by Type (2013-2018)
Table United States Rare Disease Treatment Market Size by Application (2013-2018) (Million US$)
Table United States Rare Disease Treatment Market Share by Application (2013-2018)
Figure Europe Rare Disease Treatment Market Size 2013-2018 (Million US$)
Table Europe Key Players Rare Disease Treatment Revenue (2017-2018) (Million US$)
Table Europe Key Players Rare Disease Treatment Market Share (2017-2018)
Table Europe Rare Disease Treatment Market Size by Type (2013-2018) (Million US$)
Table Europe Rare Disease Treatment Market Share by Type (2013-2018)
Table Europe Rare Disease Treatment Market Size by Application (2013-2018) (Million US$)
Table Europe Rare Disease Treatment Market Share by Application (2013-2018)
Figure China Rare Disease Treatment Market Size 2013-2018 (Million US$)
Table China Key Players Rare Disease Treatment Revenue (2017-2018) (Million US$)
Table China Key Players Rare Disease Treatment Market Share (2017-2018)
Table China Rare Disease Treatment Market Size by Type (2013-2018) (Million US$)
Table China Rare Disease Treatment Market Share by Type (2013-2018)
Table China Rare Disease Treatment Market Size by Application (2013-2018) (Million US$)
Table China Rare Disease Treatment Market Share by Application (2013-2018)
Figure Japan Rare Disease Treatment Market Size 2013-2018 (Million US$)
Table Japan Key Players Rare Disease Treatment Revenue (2017-2018) (Million US$)
Table Japan Key Players Rare Disease Treatment Market Share (2017-2018)
Table Japan Rare Disease Treatment Market Size by Type (2013-2018) (Million US$)
Table Japan Rare Disease Treatment Market Share by Type (2013-2018)
Table Japan Rare Disease Treatment Market Size by Application (2013-2018) (Million US$)
Table Japan Rare Disease Treatment Market Share by Application (2013-2018)
Figure Southeast Asia Rare Disease Treatment Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Rare Disease Treatment Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Rare Disease Treatment Market Share (2017-2018)
Table Southeast Asia Rare Disease Treatment Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Rare Disease Treatment Market Share by Type (2013-2018)
Table Southeast Asia Rare Disease Treatment Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Rare Disease Treatment Market Share by Application (2013-2018)
Figure India Rare Disease Treatment Market Size 2013-2018 (Million US$)
Table India Key Players Rare Disease Treatment Revenue (2017-2018) (Million US$)
Table India Key Players Rare Disease Treatment Market Share (2017-2018)
Table India Rare Disease Treatment Market Size by Type (2013-2018) (Million US$)
Table India Rare Disease Treatment Market Share by Type (2013-2018)
Table India Rare Disease Treatment Market Size by Application (2013-2018) (Million US$)
Table India Rare Disease Treatment Market Share by Application (2013-2018)
Figure Central & South America Rare Disease Treatment Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Rare Disease Treatment Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Rare Disease Treatment Market Share (2017-2018)
Table Central & South America Rare Disease Treatment Market Size by Type (2013-2018) (Million US$)
Table Central & South America Rare Disease Treatment Market Share by Type (2013-2018)
Table Central & South America Rare Disease Treatment Market Size by Application (2013-2018) (Million US$)
Table Central & South America Rare Disease Treatment Market Share by Application (2013-2018)
Table Novartis Company Details
Table Novartis Revenue in Rare Disease Treatment Business (2013-2018) (Million US$)
Figure Novartis Revenue Growth Rate in Rare Disease Treatment Business (2013-2018)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Rare Disease Treatment Business (2013-2018)(Million US$)
Figure Pfizer Revenue Growth Rate in Rare Disease Treatment Business (2013-2018)
Table Pfizer Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Rare Disease Treatment Business (2013-2018)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Rare Disease Treatment Business (2013-2018)
Table F. Hoffmann-La Roche Recent Development
Table Celgene Company Details
Table Celgene Revenue in Rare Disease Treatment Business (2013-2018)(Million US$)
Figure Celgene Revenue Growth Rate in Rare Disease Treatment Business (2013-2018)
Table Celgene Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Rare Disease Treatment Business (2013-2018)(Million US$)
Figure AbbVie Revenue Growth Rate in Rare Disease Treatment Business (2013-2018)
Table AbbVie Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Rare Disease Treatment Business (2013-2018)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Rare Disease Treatment Business (2013-2018)
Table Johnson & Johnson Recent Development
Table Shire Company Details
Table Shire Revenue in Rare Disease Treatment Business (2013-2018)(Million US$)
Figure Shire Revenue Growth Rate in Rare Disease Treatment Business (2013-2018)
Table Shire Recent Development
Table Alexion Company Details
Table Alexion Revenue in Rare Disease Treatment Business (2013-2018)(Million US$)
Figure Alexion Revenue Growth Rate in Rare Disease Treatment Business (2013-2018)
Table Alexion Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Rare Disease Treatment Business (2013-2018)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Rare Disease Treatment Business (2013-2018)
Table Novo Nordisk Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Rare Disease Treatment Business (2013-2018)(Million US$)
Figure Sanofi Revenue Growth Rate in Rare Disease Treatment Business (2013-2018)
Table Sanofi Recent Development
Table Bayer Company Details
Table Amgen Company Details
Table Allergan Company Details
Table Eisai Company Details
Table Bristol-Myers Squibb Company Details
Table Merck Company Details
Table Vertex Pharmaceuticals Company Details
Table Baxter Company Details
Table BioMarin Company Details
Table Teva Pharmaceutical Industries Company Details
Table Global Rare Disease Treatment Market Size by Regions (Million US$) 2018-2025
Figure Global Rare Disease Treatment Market Size Share by Regions (2018-2025)
Figure Global Rare Disease Treatment Market Size Share by Regions in 2025
Figure United States Rare Disease Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Europe Rare Disease Treatment Market Size Forecast (2018-2025)(Million USD)
Figure China Rare Disease Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Japan Rare Disease Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Rare Disease Treatment Market Size Forecast (2018-2025)(Million USD)
Figure India Rare Disease Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Rare Disease Treatment Market Size Forecast (2018-2025)(Million USD)
Table Global Rare Disease Treatment Market Size by Product (2018-2025) (Million US$)
Figure Global Rare Disease Treatment Market Size by Product (2018-2025)
Figure Global Rare Disease Treatment Market Size by Product in 2025
Table Global Rare Disease Treatment Market Size by Application (2018-2025) (Million US$)
Figure Global Rare Disease Treatment Market Size by Application (2018-2025)
Figure Global Rare Disease Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Electronic files(PDF) of market research reports will be dispatched within 12 to 24 hours. (Mon-Fri IST)

Select License Type

Need Help?
+
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.